Amyloidosis is a rare disease in which the body makes abnormal proteins, known as amyloid. These proteins build up within the body, leading to tissue and organ damage.
Certain groups of people are more likely to be diagnosed with this condition. Each type of amyloidosis tends to affect different people and comes with its own set of risk factors.
Here’s what you need to know about how common amyloidosis is and which groups are most impacted.
Health experts aren’t entirely certain about the exact number of people affected by amyloidosis, but they believe fewer than 200,000 people in the United States have the condition, or approximately 1 in 1,725 people.
Amyloidosis can resemble other diseases and may be misdiagnosed. Because of this, health experts believe the disease is underdiagnosed. This means that more people may have the condition than the numbers suggest.
As diagnostic tools improve, it’s possible that some types of amyloidosis may be much more common than previously thought.
Different demographic patterns exist among the different types of amyloidosis. Some types are more common in certain age groups or among certain racial or ethnic groups.
AL amyloidosis most often affects people who are between the ages of 50 and 80. However, some people are diagnosed with this condition much earlier in life, starting with people in their late 20s. About 67 percent of people with AL amyloidosis are men, according to the Amyloidosis Foundation.
Approximately 86 percent of people with AL amyloidosis are non-Hispanic white, 8 percent are non-Hispanic Black, and 4 percent are Hispanic.
Research has shown that minority groups develop the disease on average four to six years earlier than non-Hispanic white people. One study found that non-Hispanic Blacks tend to have more aggressive disease.
Non-Hispanic Blacks are twice as likely as non-Hispanic whites to develop multiple myeloma, a type of blood cancer that’s linked to AL amyloidosis. Rates of multiple myeloma are only slightly higher in Hispanics than non-Hispanic whites.
AA amyloidosis typically affects people who have a long-term inflammatory condition, such as an autoimmune disorder or a chronic infection. It can develop at any age and is the most common type of amyloidosis to affect children.
On average, AA amyloidosis develops around age 50. Men have a slightly higher rate of AA amyloidosis than women, according to a study published in the Journal of Internal Medicine.
In Western countries, the condition has a smaller percentage of underlying inflammatory conditions and infections and is linked more to intravenous (IV) drug use and unknown causes.
The Journal of Internal Medicine study noted that AA amyloidosis of unknown cause is more likely to occur in women, older adults, and people with a higher body mass index and obesity.
ATTRwt amyloidosis most commonly affects older men and develops on average at age 75, according to the Amyloidosis Foundation. Although the condition was once considered rare in women, Cleveland Clinic notes that improved diagnostic tools indicate that women may develop ATTRwt amyloidosis at much higher rates than previously thought.
Hereditary ATTR affects people who have a genetic mutation (change) that is inherited from a parent. If your parent has hereditary amyloidosis, you have a 50 percent chance of having the mutated gene, but that doesn’t mean you will develop hATTR. Men have a greater risk of developing hATTR, per Cleveland Clinic.
Approximately 3 to 4 percent of Black Americans have a genetic mutation known as p.Val142Ile (also called Val122Ile). This mutation can cause hATTR, although some people have the genetic change and don’t develop the condition.
Some countries have higher rates of hATTR, including Japan, Sweden, Portugal, and Ireland.
You can discuss your individual risk factors for amyloidosis with your doctor. Based on your medical history, family history, and symptoms, your doctor can determine if you may need certain tests to evaluate your condition.
Because amyloidosis is believed to be underdiagnosed and look like other conditions, it’s important to seek an accurate diagnosis if you experience heart problems or other related conditions.
Signs and symptoms of amyloidosis can vary among individuals and include shortness of breath, unexplained weight loss, blood in urine, irregular heartbeat, tingling in hands and feet, diarrhea, and dizziness.
An early diagnosis can help you get appropriate treatment that can improve your quality of life and outlook.
Get updates directly to your inbox.
Is there a local group in London re amaloidosis
Become a member to get even more
This is a member-feature!
Sign up for free to view article comments.
We'd love to hear from you! Please share your name and email to post and read comments.
You'll also get the latest articles directly to your inbox.